Trial Profile
Eezetimibe effect on chylomicrons in patients with coronary disorders
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary)
- Indications Coronary disorders
- Focus Pharmacodynamics; Therapeutic Use
- 07 Dec 2015 New trial record